Cite
Are Biopharma Firms Discontinuing Doomed Drug Discovery Projects Fast Enough?
MLA
Subramanian, Annapoornima M., et al. “Are Biopharma Firms Discontinuing Doomed Drug Discovery Projects Fast Enough?” Production & Operations Management, vol. 31, no. 4, Apr. 2022, pp. 1454–55. EBSCOhost, https://doi.org/10.1111/poms.13621.
APA
Subramanian, A. M., Lévesque, M., & Van De Vrande, V. (2022). Are Biopharma Firms Discontinuing Doomed Drug Discovery Projects Fast Enough? Production & Operations Management, 31(4), 1454–1455. https://doi.org/10.1111/poms.13621
Chicago
Subramanian, Annapoornima M., Moren Lévesque, and Vareska Van De Vrande. 2022. “Are Biopharma Firms Discontinuing Doomed Drug Discovery Projects Fast Enough?” Production & Operations Management 31 (4): 1454–55. doi:10.1111/poms.13621.